Table 2.
Laboratory findings of the 115 COVID-19 patients.
| Variables (Normal reference range) | n (%) |
|---|---|
| WBC [(3.5–9.5) × 109/L] <3.5 × 109/L (3.5–9.5) × 109/L >9.5 × 109/L |
11 (9.6) 101 (87.8) 3 (2.6) |
| N [(1.8–6.3) × 109/L] <1.8 × 109/L (1.8–6.3) × 109/L >6.3 × 109/L |
6 (5.2) 93 (80.9) 16 (13.9) |
| L [ (1.1–3.2) × 109/L] <1.1 × 109/L (1.1–3.2) × 109/L >3.2 × 109/L |
50 (43.5) 64 (55.7) 1 (0.9) |
| Hb(130–175 g/L) <130 g/L 130–175 g/L >175 g/L |
67 (58.3) 46 (40.0) 2 (1.7) |
| AST (8–40 U/L) <8 U/L 8–40 U/L >40 U/L |
0 (0.0) 9077.4) 25 (21.7) |
| ALT (5–40 U/L) <5 U/L 5–40 U/L >40 U/L |
0 (0.0) 66 (57.4) 49 (42.6) |
| LDH (109–245 U/L) <109 U/L 109–245 U/L >245 U/L |
0 (0.0) 72 (62.6) 43 (37.4) |
| PA (150–400 mg/L) <150 mg/L 150–400 mg/L >400 mg/L |
47 (40.9) 63 (54.8) 5 (4.3) |
| ALB (33–55 g/L) <33 g/L 33–55 g/L >55 g/L |
72 (62.6) 43 (37.4) 0 (0.0) |
| ALB/GLB (1.5–2.5) <1.5 1.5–2.5 >2.5 |
91 (79.1) 23 (20.0) 1 (0.9) |
| Uric acid (208–428 μmol/L) <208 μmol/L 208–428 μmol/L >428 μmol/L |
26 (22.6) 78 (67.8) 11 (9.6) |
| GLU (3.9–6.1 mmol/L) <3.9 mmol/L 3.9–6.1 mmol/L >6.1 mmol/L |
0 (0.0) 47 (40.9) 68 (59.1) |
| TG (0–1.7 mmol/L) 0–1.7 mmol/L >1.7 mmol/L |
76 (66.1) 39 (33.9) |
| HDLC (1.04–1.66 mmol/L) <1.04 mmol/L 1.04–1.66 mmol/L >1.66 mmol/L |
75 (65.2) 36 (31.3) 4 (3.5) |
| LDLC (0–3.12 mmol/L) 0–3.12 mmol/L >3.12 mmol/L |
84 (73.0) 31 (27.0) |
| CRP (0–8 mg/L)a 0–8 mg/L >8 mg/L |
54 (48.6) 57 (51.4) |
| HCY (0–20 μmol/L)b 0–20 μmol/L >20 μmol/L |
88 (95.7) 4 (4.3) |
| CycC (0.55–1.05 mg/L)c <0.55 mg/L 0.55–1.05 mg/L >1.05 mg/L |
1 (0.9) 92 (83.6) 17 (15.5) |
a Data missing in 4 cases, b Data missing in 23 cases, cData missing in 5 cases.